These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29079060)

  • 1. Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.
    Pawełczyk T; Piątkowska-Janko E; Bogorodzki P; Gębski P; Grancow-Grabka M; Trafalska E; Żurner N; Pawełczyk A
    Schizophr Res; 2018 May; 195():168-175. PubMed ID: 29079060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.
    Pawełczyk T; Grancow-Grabka M; Żurner N; Pawełczyk A
    Schizophr Res; 2021 Apr; 230():61-68. PubMed ID: 33684737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase level increase is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized clinical trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():142-148. PubMed ID: 29241838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
    Pawełczyk T; Grancow-Grabka M; Kotlicka-Antczak M; Trafalska E; Pawełczyk A
    J Psychiatr Res; 2016 Feb; 73():34-44. PubMed ID: 26679763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods.
    Pawełczyk T; Grancow M; Kotlicka-Antczak M; Trafalska E; Gębski P; Szemraj J; Żurner N; Pawełczyk A
    BMC Psychiatry; 2015 May; 15():97. PubMed ID: 25934131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
    Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
    Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment.
    Köbe T; Witte AV; Schnelle A; Lesemann A; Fabian S; Tesky VA; Pantel J; Flöel A
    Neuroimage; 2016 May; 131():226-38. PubMed ID: 26433119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cortical thickness in first episode schizophrenia.
    Schultz CC; Koch K; Wagner G; Roebel M; Schachtzabel C; Gaser C; Nenadic I; Reichenbach JR; Sauer H; Schlösser RG
    Schizophr Res; 2010 Feb; 116(2-3):204-9. PubMed ID: 19926451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication.
    Nesvåg R; Lawyer G; Varnäs K; Fjell AM; Walhovd KB; Frigessi A; Jönsson EG; Agartz I
    Schizophr Res; 2008 Jan; 98(1-3):16-28. PubMed ID: 17933495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.
    Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS
    JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies.
    Vita A; De Peri L; Deste G; Barlati S; Sacchetti E
    Biol Psychiatry; 2015 Sep; 78(6):403-12. PubMed ID: 25802081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study.
    Kumari V; Aasen I; ffytche D; Williams SC; Sharma T
    Neuroimage; 2006 Jan; 29(2):545-56. PubMed ID: 16181792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Pawełczyk A
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():7-13. PubMed ID: 28651701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.
    Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM
    J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
    Roiz-Santiáñez R; Tordesillas-Gutiérrez D; Ortíz-García de la Foz V; Ayesa-Arriola R; Gutiérrez A; Tabarés-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2012 Oct; 141(1):22-8. PubMed ID: 22884754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.